Product Program year 2025 Source: CMS Open Payments

Gelclair Concentrated Oral Gel

Device Oncology

PDI 00370564456156

Open in the dashboard

General payments

$3,954

144 payments

Research payments

$0

0 payments

Through program year 2025, $3,954 in general payments and $0 in research payments were reported against Gelclair Concentrated Oral Gel (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $2,552 96
2024 General $1,402 48

Breakdown

Who paid General payments · program years 2024–2025
  1. Napo Pharmaceuticals Inc $3,954 144 payments
Top recipients General payments · program year 2025
  1. Leslie Worona Nurse Practitioner, Family · New York, NY $299 12% · 7 payments
  2. Krzysztof Misiukiewicz Medical Oncology · New York, NY $116 5% · 5 payments
  3. Catherine Concert Nurse Practitioner, Family · New York, NY $100 4% · 1 payment
  4. Bevery Smith Nurse Practitioner · New York, NY $100 4% · 1 payment
  5. Georges Hobeika Radiation Oncology · West Palm Beach, FL $89 3% · 2 payments

The top 5 of 75 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Radiation Oncology Radiology $961 38% · 35 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $467 18% · 5 practitioners
  3. Hematology & Oncology Internal Medicine $323 13% · 13 practitioners
  4. Medical Oncology Internal Medicine $274 11% · 8 practitioners
  5. Nurse Practitioner $178 7% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $945 37% · 12 recipients
  2. Florida $747 29% · 27 recipients
  3. California $739 29% · 30 recipients
  4. Arizona $42 2% · 3 recipients
  5. Texas $29 1% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

144 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record